Charlene E. McEvoy, MD, MPH

HealthPartners Institute

Disclosure(s): Astra Zeneca: Grant/Research Support; Centers for Disease Control and Prevention: Grant/Research Support; Department of Defense: Grant/Research Support; GlaxoSmithKline: Grant/Research Support; National Institutes of Health: Grant/Research Support; PCORI: Grant/Research Support

Poster(s):

• (P-1435) Effectiveness of RSV Immunization among Infants in Their First RSV Season in the United States, 2023-2024 and 2024-2025 Seasons
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1501) Effectiveness of 2024–2025 seasonal influenza vaccines against influenza–associated hospitalizations among adults — VISION Network
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1517) Adult Respiratory Syncytial Virus Vaccination Receipt among Adults Testing Negative for RSV – VISION Network, October 1, 2024—March 31, 2025
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET